# Armata Pharmaceuticals, Inc.: filings

ARMP · NYSE · CIK 921114 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/armp.md) · [Financials](/companies/armp/financials.md) · [Filings](/companies/armp/filings.md) · [Insiders](/companies/armp/insiders.md)

## Reports and events: 330 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 197, 4 143, 10-Q 41, 3 34, CORRESP 33, UPLOAD 31, SC 13G 19, DEF 14A 18, EFFECT 18, S-1/A 17, SC 13D/A 15, SC 13G/A 15, 10-K 14, 424B3 14, CT ORDER 12, PRE 14A 11, S-8 11, DEFA14A 10, S-8 POS 9, S-3 8, S-1 7, 10-Q/A 5, 424B5 5, POS AM 5, 10-12G/A 4, 10-K/A 4, 8-K/A 4, ARS 4, D 4, SC 13D 4, SCHEDULE 13D/A 4, 3/A 3, 424B4 3, FWP 3, S-3/A 3, 5 2, D/A 2, NT 10-K 2, NT 10-Q 2, POS EX 2, RW 2, 10-12G 1, 15-12G 1, 15-12G/A 1, 25 1, 8-A12B 1, CERTNYS 1, DEFM14A 1, PREM14A 1, PRER14A 1, S-1MEF 1, SC 13E3 1, SC 13E3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 07:10 ET | [8-K](/filings/0001104659-26-109809.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109809 |
| 2026-09-14 | 07:12 ET | [8-K](/filings/0001104659-26-107253.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-107253 |
| 2026-08-12 | 16:23 ET | [10-Q](/filings/0001104659-26-094907.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094907 |
| 2026-08-12 | 16:16 ET | [8-K](/filings/0001104659-26-094896.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094896 |
| 2026-07-20 | 07:13 ET | [8-K](/filings/0001104659-26-084861.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-084861 |
| 2026-07-20 | 07:12 ET | [8-K](/filings/0001104659-26-084860.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-084860 |
| 2026-07-13 | 07:11 ET | [8-K](/filings/0001104659-26-082850.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082850 |
| 2026-06-24 | 16:19 ET | [8-K/A](/filings/0001104659-26-077313.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-077313 |
| 2026-06-23 | 07:10 ET | [8-K](/filings/0001104659-26-076627.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076627 |
| 2026-06-16 | 16:43 ET | [8-K](/filings/0001104659-26-074618.md) | 5.07 Shareholder vote results | 0001104659-26-074618 |
| 2026-05-13 | 17:21 ET | [SCHEDULE 13D/A](/filings/0001104659-26-060384.md) | Ownership report, active investor, amended | 0001104659-26-060384 |
| 2026-05-13 | 16:49 ET | [10-Q](/filings/0001104659-26-060333.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060333 |
| 2026-05-13 | 16:33 ET | [8-K](/filings/0001104659-26-060299.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-060299 |
| 2026-05-07 | 07:10 ET | [8-K](/filings/0001104659-26-056658.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056658 |
| 2026-04-27 | 16:10 ET | [DEF 14A](/filings/0001104659-26-049437.md) | Proxy statement, period 2026-06-11 | 0001104659-26-049437 |
| 2026-04-27 | 07:10 ET | [8-K](/filings/0001104659-26-048997.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-048997 |
| 2026-04-02 | 16:16 ET | [8-K](/filings/0001104659-26-039180.md) | 8.01 Other events | 0001104659-26-039180 |
| 2026-03-25 | 16:18 ET | [10-K](/filings/0001104659-26-034532.md) | Annual report, period 2025-12-31 | 0001104659-26-034532 |
| 2026-03-25 | 16:11 ET | [8-K](/filings/0001104659-26-034523.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034523 |
| 2026-03-19 | 07:10 ET | [8-K](/filings/0001104659-26-031715.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-031715 |
| 2026-02-23 | 07:10 ET | [8-K](/filings/0001104659-26-018333.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018333 |
| 2026-01-26 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001140361-26-002376.md) | Ownership report, active investor, amended | 0001140361-26-002376 |
| 2026-01-26 | 08:00 ET | [8-K](/filings/0001104659-26-006446.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-006446 |
| 2026-01-13 | 07:10 ET | [8-K](/filings/0001104659-26-003076.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003076 |
| 2025-12-01 | 17:17 ET | [8-K](/filings/0001104659-25-117387.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-117387 |
| 2025-11-12 | 16:16 ET | [10-Q](/filings/0001104659-25-110383.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110383 |
| 2025-11-12 | 16:10 ET | [8-K](/filings/0001104659-25-110351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110351 |
| 2025-10-22 | 11:15 ET | [8-K](/filings/0001104659-25-101447.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101447 |
| 2025-09-11 | 18:15 ET | [8-K](/filings/0001104659-25-089150.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-089150 |
| 2025-08-12 | 21:38 ET | [SCHEDULE 13D/A](/filings/0001140361-25-030666.md) | Ownership report, active investor, amended | 0001140361-25-030666 |
| 2025-08-12 | 16:36 ET | [10-Q](/filings/0001558370-25-011235.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011235 |
| 2025-08-12 | 16:16 ET | [8-K](/filings/0001558370-25-011227.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011227 |
| 2025-06-13 | 16:05 ET | [8-K](/filings/0001104659-25-059346.md) | 5.07 Shareholder vote results | 0001104659-25-059346 |
| 2025-05-19 | 07:06 ET | [8-K](/filings/0001104659-25-050219.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-050219 |
| 2025-05-14 | 16:23 ET | [10-Q](/filings/0001558370-25-007765.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007765 |
| 2025-05-14 | 16:13 ET | [8-K](/filings/0001558370-25-007752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007752 |
| 2025-05-01 | 07:07 ET | [8-K](/filings/0001104659-25-043017.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-043017 |
| 2025-04-28 | 17:01 ET | [DEF 14A](/filings/0001104659-25-040273.md) | Proxy statement, period 2025-06-12 | 0001104659-25-040273 |
| 2025-04-02 | 16:05 ET | [8-K](/filings/0001104659-25-031127.md) | 8.01 Other events | 0001104659-25-031127 |
| 2025-03-21 | 20:32 ET | [10-K](/filings/0001558370-25-003406.md) | Annual report, period 2024-12-31 | 0001558370-25-003406 |
| 2025-03-21 | 20:30 ET | [8-K](/filings/0001558370-25-003405.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003405 |
| 2025-03-12 | 17:49 ET | [SCHEDULE 13D/A](/filings/0001140361-25-008466.md) | Ownership report, active investor, amended | 0001140361-25-008466 |
| 2025-03-12 | 17:14 ET | [8-K](/filings/0001104659-25-023015.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-023015 |
| 2024-12-19 | 07:38 ET | [8-K](/filings/0001104659-24-129981.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129981 |
| 2024-12-04 | 16:05 ET | [8-K](/filings/0001104659-24-125505.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-125505 |
| 2024-11-15 | 16:05 ET | [8-K](/filings/0001104659-24-119701.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-119701 |
| 2024-11-14 | 16:17 ET | [SC 13D/A](/filings/0001140361-24-046918.md) | Ownership report, active investor, amended | 0001140361-24-046918 |
| 2024-11-13 | 16:15 ET | [10-Q](/filings/0001558370-24-015530.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015530 |
| 2024-11-13 | 16:10 ET | [8-K](/filings/0001558370-24-015526.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015526 |
| 2024-11-12 | 07:07 ET | [8-K](/filings/0001104659-24-116327.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-116327 |

Page 1 of 7. [Older](/companies/armp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.